Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Flagship Ventures Fund V General Partner LLC Insider Profile
4 Followers
Flagship Ventures Fund V General Partner LLC, Director, Ten Percent Owner at Kaleido Biosciences, holds 0.00 shares in Sigilon Therapeutics (Ticker: SGTX), holds 33.29M shares in Sana Biotechnology (Ticker: SANA), holds 3.54M shares in Codiak BioSciences (Ticker: CDAKQ).
Flagship Ventures Fund V General Partner LLC Kaleido Biosciences (KLDO)Director, Ten Percent Owner
Kaleido Biosciences (KLDO)
Director, Ten Percent Owner
Ranked #80,437 out of 98,624 Corporate Insiders
Profitable Transactions
1 out of 5 Profitable Transactions
Average Return
-22.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Flagship Ventures Fund V General Partner LLC's holdings
Insider Roles
Roles that Flagship Ventures Fund V General Partner LLC holds in companies
Most Profitable Insider Trade
Stock:
Codiak BioSciences
(CDAKQ)
(CDAKQ)
Rating:Informative Buy
Date:Oct 20, 2020 - Oct 20, 2021
Return:+27.30%
The most profitable trade made by Flagship Ventures Fund V General Partner LLC
Flagship Ventures Fund V General Partner LLC's Trading History
Kaleido Biosciences
Mar 06, 2019
Director, Ten Percent Owner
Uninformative Buy
―
$47.44K
Codiak BioSciences
Sep 16, 2022
―
Uninformative Buy
―
$38.95K
Foghorn Therapeutics
Oct 29, 2020
Ten Percent Owner
Uninformative Buy
―
$10.11M
Sana Biotechnology
Jun 08, 2023
Ten Percent Owner
Informative Sell
2.53M
$299.61M
Sigilon Therapeutics
Aug 15, 2023
―
Uninformative Sell
11.90M
$0.00
List of latest transactions for each holding click on a transaction to see Flagship Ventures Fund V General Partner LLC's performance on stock
You May Also Like
Flagship Ventures Fund V General Partner LLC insider profile FAQ
What is the percentage of profitable transactions made by Flagship Ventures Fund V General Partner LLC?
The percentage of profitable transactions made by Flagship Ventures Fund V General Partner LLC is 20%.
What is the average return per transaction made by Flagship Ventures Fund V General Partner LLC?
The average return per transaction made by Flagship Ventures Fund V General Partner LLC is -22.40%.
What stocks does Flagship Ventures Fund V General Partner LLC hold?
Flagship Ventures Fund V General Partner LLC holds: KLDO, CDAKQ, FHTX, SANA, SGTX stocks.
What was Flagship Ventures Fund V General Partner LLC’s latest transaction?
Flagship Ventures Fund V General Partner LLC latest transaction was an Uninformative Sell of $11.90M.
What was Flagship Ventures Fund V General Partner LLC's most profitable transaction?
Flagship Ventures Fund V General Partner LLC’s most profitable transaction was an Informative Buy of CDAKQ stock on October 20, 2020. The return on the trade was 27.30%.
What is Flagship Ventures Fund V General Partner LLC's role in Kaleido Biosciences?
Flagship Ventures Fund V General Partner LLC's role in Kaleido Biosciences is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.